Past studies suggest that SRSF1 could activate MAPK signaling, partially due to the upregulation of interleukin 1 receptor type 1 (IL1R1) through alternative-splicing-regulated mRNA stability to trigger pancreatic ductal adenocarcinoma (PDAC) [23]. The gene discussed is IL1R1; the disease is pancreatic ductal adenocarcinoma.